Evidence map›Paper›PMID 32660953›Full record

ArticleBMJ open2020

Novel education-based intervention to reduce inappropriate antibiotic prescribing for treatment of gonorrhoea in China: protocol for a cluster randomised controlled trial.

Ting-Ting Jiang, Yun-Qing Yang, Ning-Xiao Cao, Yue-Ping Yin, Xiang-Sheng Chen

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Increased Involvement ofHealthcare (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ting-Ting JiangInstitute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China.ORCID 0000-0002-0789-8816
Yun-Qing YangDepartment of prevention and health care, Guangzhou Institute of Dermatology, Guangzhou, China.
Ning-Xiao CaoInstitute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China.
Yue-Ping YinInstitute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China.
Xiang-Sheng ChenInstitute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China chenxs@ncstdlc.org.ORCID 0000-0003-3927-2065
Chinese Center For Disease Control and Prevention · CNGuangzhou Institute of Dermatology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInappropriate use of antibiotics to treat gonorrhoea can lead to antibiotic resistance. Education programmes may be helpful for improving physician prescribing behaviours in accordance with treatment guidelines. As traditional education based on printed materials may have limited effect on guideline-based treatment, innovative education strategies are needed. The current trial aims to assess the effectiveness of a novel education intervention to increase guideline-based treatment of gonorrhoea in China. METHODS AND ANALYSIS: We will conduct a two-arm cluster randomised control trial at 144 hospitals (clusters) in eight Chinese provinces. The intervention will include an online training video developed on the WenJuanXing platform that covers workflows and requirements for managing a patient with uncomplicated gonorrhoea. Outpatient physicians in dermatology (dermatovenerology), urology, andrology and gynaecology will be given access to the video via a quick response code. In hospitals allocated to the control arm, physicians will continue to participate in their standard of care training programme. The primary outcome is the proportion of gonorrhoea antibiotic prescriptions adherent to Chinese national guidelines at the cluster level. In addition, to understand the reasons of physician's non-adherence to the intervention by conducting a questionnaire survey will be considered as the secondary outcome of the study. ETHICS AND DISSEMINATION: Ethical approval was obtained from the Medical Ethics Committee of the Chinese Academy of Medical Sciences Institute of Dermatology (2020-LS-004). All physicians will provide an informed consent prior to participating in the study. Findings of the trial will be disseminated through conferences and peer-reviewed journals, and will be used to develop training programmes for physicians. TRIAL REGISTRATION NUMBER: ChiCTR2000029591.

Indexed as

GonorrheaAnti-Bacterial AgentsChinaHumansInappropriate PrescribingPrimary Health CareRandomized Controlled Trials as TopicRespiratory Tract InfectionsAnti-Bacterial Agentsinfection controlinfectious diseases & infestationsurinary tract infections

Identifiers

PMID32660953
PMCPMC7359379
OpenAlexW3041315164

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.